Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
240 USD | -0.17% |
|
-5.36% | +3.74% |
07-02 | Evercore ISI Cuts Price Target on Danaher to $260 From $266, Maintains Outperform Rating | MT |
06-27 | FDA Approves Danaher Unit's Rapid Test for Hepatitis C | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.74% | 178B | |
+0.91% | 204B | |
+28.89% | 154B | |
+31.66% | 112B | |
+2.02% | 64.16B | |
+19.45% | 54.88B | |
-3.44% | 46.69B | |
-9.28% | 36.8B | |
-0.10% | 35.26B | |
+10.10% | 27.82B |
- Stock Market
- Equities
- DHR Stock
- News Danaher Corporation
- Transcript : Danaher Corp. Presents at JPMorgan 34th Annual Healthcare Conference, Jan-12-2016 11